KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Operating Expenses (2020 - 2025)

Organon (OGN) has 6 years of Operating Expenses data on record, last reported at $531.0 million in Q4 2025.

  • For Q4 2025, Operating Expenses fell 12.66% year-over-year to $531.0 million; the TTM value through Dec 2025 reached $2.2 billion, down 28.67%, while the annual FY2025 figure was $2.2 billion, 3.45% down from the prior year.
  • Operating Expenses reached $531.0 million in Q4 2025 per OGN's latest filing, up from $499.0 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $1.5 billion in Q4 2023 and bottomed at $110.0 million in Q4 2021.
  • Average Operating Expenses over 5 years is $936.8 million, with a median of $1.1 billion recorded in 2021.
  • Peak YoY movement for Operating Expenses: soared 1734.85% in 2021, then crashed 64.42% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $110.0 million in 2021, then surged by 1149.09% to $1.4 billion in 2022, then increased by 8.73% to $1.5 billion in 2023, then plummeted by 59.3% to $608.0 million in 2024, then fell by 12.66% to $531.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $531.0 million in Q4 2025, $499.0 million in Q3 2025, and $550.0 million in Q2 2025.